Artelo Biosciences, Inc.
Artelo Biosciences, Inc. (ARTL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARTL · as of Jun 9, 2026
Key Statistics
Explore Artelo Biosciences, Inc. Data
artl stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 50.0%
Competitors & Peers
artl competitorsARTL
CARM
GTBP
LIPO
PBM
PTIXStock Performance
Full HistoryAbout Artelo Biosciences, Inc.
Artelo Biosciences, Inc. functions as a clinical-stage biopharmaceutical enterprise dedicated to discovering and advancing therapies that modulate the endocannabinoid system. The company's robust deve…
what is artelo biosciences, inc. · artl stock overview · artelo biosciences, inc. company profile · who is artelo biosciences, inc. ceo · artl NASDAQ · artelo biosciences, inc. headquarters · artelo biosciences, inc. business segments
About Stock Overview & Key Data
Artelo Biosciences, Inc. (ARTL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 21, 2019. As of the latest trading session, ARTL stock price is $1.33, with a market capitalization of $3.1M. The stock has returned -79.85% over the past 12 months and +9.02% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Artelo Biosciences, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Artelo Biosciences, Inc. reported revenue of — and net income of -$12.9M. For detailed data — including Artelo Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Artelo Biosciences, Inc. (ARTL) stock price is $1.33. The stock is traded on NASDAQ under the ticker symbol ARTL. The 52-week range is $1.19 – $85.80.